Court restricts abortion access across the US by blocking the mailing of mifepristone
Briefly

Court restricts abortion access across the US by blocking the mailing of mifepristone
""Every abortion facilitated by FDA's action cancels Louisiana's ban on medical abortions and undermines its policy that 'every unborn child is human being from the moment of conception and is, therefore, a legal person.'""
""This is going to affect patients' access to abortion and miscarriage care in every state in the nation. When telemedicine is restricted, rural communities, people with low incomes, people with disabilities, survivors of intimate partner violence and communities of color suffer the most.""
A federal appeals court has ruled that Mifepristone, a common abortion pill, must be distributed only in person at clinics, blocking mail prescriptions. This decision undermines Louisiana's abortion ban and reflects ongoing FDA reviews of the drug's safety. The ruling highlights concerns about access to abortion and miscarriage care, particularly affecting vulnerable populations. Legal challenges have emerged, with state officials seeking to revert to stricter regulations on the pill's distribution, impacting access nationwide since the Supreme Court's 2022 decision on abortion rights.
Read at ABC7 Los Angeles
Unable to calculate read time
[
|
]